Novartis AG (LON:0QLR)

Akoya Biosciences Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 11, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	172,976	156,316	162,643	161,382	145,494	157,509
Market Cap Growth	0.08%	-3.89%	0.78%	10.92%	-7.63%	-2.92%
Enterprise Value	191,903	170,040	173,261	169,844	165,439	178,432
Last Close Price	88.47	75.36	73.16	64.00	52.91	55.14
PE Ratio	17.36	16.39	13.95	27.96	8.20	26.64
PS Ratio	4.29	3.78	4.44	4.47	4.48	4.31
PB Ratio	5.64	4.43	4.43	3.27	2.91	3.80
P/TBV Ratio	-	-	-	69.00	21.01	-
P/FCF Ratio	12.26	12.04	15.46	14.60	14.07	17.38
P/OCF Ratio	11.40	11.11	14.33	13.66	13.07	15.75
EV/Sales Ratio	4.77	4.12	4.73	4.71	5.09	4.88
EV/EBITDA Ratio	11.06	10.30	12.60	14.68	14.33	16.32
EV/EBIT Ratio	13.74	13.04	17.46	22.21	20.43	24.00
EV/FCF Ratio	13.61	13.10	16.47	15.36	16.00	19.69
Debt / Equity Ratio	0.78	0.71	0.57	0.47	0.46	0.67
Debt / EBITDA Ratio	1.37	1.50	1.49	1.97	1.95	2.49
Debt / FCF Ratio	1.69	1.93	1.97	2.10	2.22	3.08
Asset Turnover	0.55	0.51	0.43	0.35	0.34	0.41
Inventory Turnover	2.17	2.20	1.84	1.67	1.65	2.31
Quick Ratio	0.50	0.79	0.88	1.00	1.25	0.65
Current Ratio	0.82	1.03	1.16	1.29	1.51	0.90
Return on Equity (ROE)	32.49%	26.27%	16.15%	9.51%	36.80%	14.38%
Return on Assets (ROA)	11.88%	10.09%	7.27%	4.62%	5.28%	5.16%
Return on Capital (ROIC)	16.47%	13.72%	9.84%	6.18%	7.08%	7.07%
Return on Capital Employed (ROCE)	26.40%	22.20%	17.20%	10.40%	10.80%	10.70%
Earnings Yield	5.76%	6.10%	7.17%	3.58%	12.19%	3.75%
FCF Yield	8.15%	8.30%	6.47%	6.85%	7.11%	5.75%
Dividend Yield	3.28%	4.09%	4.21%	4.49%	4.75%	4.50%
Payout Ratio	57.26%	63.85%	48.85%	107.92%	30.67%	86.56%
Buyback Yield / Dilution	3.37%	2.73%	4.78%	2.79%	1.57%	0.99%
Total Shareholder Return	6.65%	6.82%	8.98%	7.28%	6.31%	5.50%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.